Back
NewAmsterdam Pharma Co NV Stock Price Chart
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
41
NAMS
NewAmsterdam Pharma Co NV
Last Price:
$23.57
Seasonality Move:
14.74%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
The current trend is moderately bearish and NAMS is experiencing slight selling pressure.
NewAmsterdam Pharma Co NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.47 | Sell |
| 20-day SMA: | 25.27 | Sell |
| 50-day SMA: | 23.48 | Buy |
| 200-day SMA: | 19.82 | Buy |
| 8-day EMA: | 24.26 | Sell |
| 20-day EMA: | 24.53 | Sell |
| 50-day EMA: | 23.25 | Buy |
| 200-day EMA: | 19.9 | Buy |
NewAmsterdam Pharma Co NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 44.17 | Sell |
| Chaikin Money Flow: | -219851 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.43 - 26.13) | Sell |
| Bollinger Bands (100): | (16.57 - 24.09) | Buy |
NewAmsterdam Pharma Co NV Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NewAmsterdam Pharma Co NV Stock
Is NewAmsterdam Pharma Co NV Stock a Buy?
-
NewAmsterdam Pharma Co NV share price is 23.55 while NAMS 8-day simple moving average is 24.47, which is a Sell signal.
-
The stock price of NAMS is 23.55 while NewAmsterdam Pharma Co NV 20-day SMA is 25.27, which makes it a Sell.
-
NewAmsterdam Pharma Co NV 50-day simple moving average is 23.48 while NAMS share price is 23.55, making it a Buy technically.
-
NAMS stock price is 23.55 and NewAmsterdam Pharma Co NV 200-day simple moving average is 19.82, creating a Buy signal.
NAMS Technical Analysis vs Fundamental Analysis
Sell
41
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
Is NewAmsterdam Pharma Co NV a Buy or a Sell?
-
NewAmsterdam Pharma Co NV stock is rated a SellThe current NewAmsterdam Pharma Co NV [NAMS] share price is $23.55. The Score for NAMS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
NewAmsterdam Pharma Co NV Stock Info
Market Cap:
2.2B
Price in USD:
23.55
Share Volume:
547.3K
NewAmsterdam Pharma Co NV 52-Week Range
52-Week High:
27.29
52-Week Low:
15.19
Sell
41
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
NewAmsterdam Pharma Co NV Share Price Forecast
-
What is the NewAmsterdam Pharma Co NV stock price today?The NewAmsterdam Pharma Co NV stock price is 23.55 USD today.
-
Will NAMS stock go up or go down?NewAmsterdam Pharma Co NV> share price is forecast to RISE/FALL based on technical indicators
-
Is NewAmsterdam Pharma Co NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NewAmsterdam Pharma Co NV is overvalued.
Is NewAmsterdam Pharma Co NV Stock a Buy?
-
NewAmsterdam Pharma Co NV share price is 23.55 while NAMS 8-day exponential moving average is 24.26, which is a Sell signal.
-
The stock price of NAMS is 23.55 while NewAmsterdam Pharma Co NV 20-day EMA is 24.53, which makes it a Sell.
-
NewAmsterdam Pharma Co NV 50-day exponential moving average is 23.25 while NAMS share price is 23.55, making it a Buy technically.
-
NAMS stock price is 23.55 and NewAmsterdam Pharma Co NV 200-day simple moving average is 19.90, creating a Buy signal.
Fundamental Analysis of NewAmsterdam Pharma Co NV
Is NewAmsterdam Pharma Co NV a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.08 per share.
Technical Analysis of NewAmsterdam Pharma Co NV
Should I short NewAmsterdam Pharma Co NV stock?
-
NAMS Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting NewAmsterdam Pharma Co NV is a Buy
-
NewAmsterdam Pharma Co NV Relative Strength Index (RSI) is 44.17, which suggest NewAmsterdam Pharma Co NV is oversold
-
The Bollinger Bands (25) for NewAmsterdam Pharma Co NV is (24.43 - 26.13), which suggest NewAmsterdam Pharma Co NV is a Buy
-
The Bollinger Bands (100) for NewAmsterdam Pharma Co NV is (16.57 - 24.09), which suggest NewAmsterdam Pharma Co NV is a Buy
* NewAmsterdam Pharma Co NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.